
Brimonidine - DermNet
Aug 1, 2013 · Brimonidine is the first and only FDA-approved topical treatment specifically developed and indicated for facial erythema in rosacea. Applied once daily, brimonidine works …
Brimonidine. Key clinical-trial evidence - DermNet
Aug 1, 2013 · Key clinical-trial evidence for brimonidine. Authoritative facts about the skin from DermNet New Zealand.
Rosacea: Symptoms, Causes, and Management - DermNet
Rosacea is a chronic facial rash that most often starts between the age of 30 and 60 years. It is common in those with fair skin, blue eyes, and Celtic origins.
Topical skin treatments - DermNet
Link to DermNet's pages about skin creams, lotions, ointments, solutions and potions. Aciclovir Acne treatment Alpha hydroxyacids Anaesthetics (anesthestics) Antibacterial soap Azelaic …
Poikiloderma of Civatte
Who gets poikiloderma of Civatte? Poikiloderma of Civatte is most common among middle-aged and elderly fair-skinned individuals, especially among those who are significantly exposed to …
Spider telangiectasis - DermNet
Spider telangiectasis, Spider angioma, Spider naevus, Naevus araneus. Authoritative facts from the DermNet New Zealand Trust.
- [PDF]
Patient-info-rosacea
Cool compresses for flushing Warm compresses, gentle eyelash/lid cleansing, and eye drops for ocular rosacea Medications for redness eg, oxymetazoline cream, brimonidine gel, beta …